Phoenix, AZ
United States
ARMI | BioFabUSA will attend Meeting on the Mesa 2026 to engage with leaders across the cell and gene therapy community, strengthen strategic partnerships, and participate in discussions focused on translating scientific innovation into scalable, commercially viable products. The event aligns closely with ARMI’s mission to accelerate the development and manufacturing of regenerative medicine technologies while strengthening domestic biomanufacturing capabilities.
The Cell & Gene Meeting on the Mesa is one of the premier annual conferences dedicated to advancing the commercialization of cell and gene therapies. Bringing together more than 1,500 industry leaders, investors, technology developers, manufacturers, and healthcare innovators, the event serves as a critical forum for addressing the challenges and opportunities shaping the future of advanced therapies.